(Q43037177)

English

Impact of viral amino acid substitutions and host interleukin-28b polymorphism on replication and susceptibility to interferon of hepatitis C virus

scientific article published on 2 August 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Impact of viral amino acid substitutions and host interleukin-28b polymorphism on replication and susceptibility to interferon of hepatitis C virus (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

Kazuaki Chayama

12

object named as

Kazuaki Chayama

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

3

object named as

Michio Imamura

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

4

object named as

Masataka Tsuge

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Shoichi Takahashi

5

object named as

Shoichi Takahashi

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

7

object named as

Hidenori Ochi

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

6

object named as

C Nelson Hayes

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Nobuhiko Hiraga

1

object named as

Nobuhiko Hiraga

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Hiromi Abe

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Chise Tateno

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Katsutoshi Yoshizato

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Yusuke Nakamura

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Naoyuki Kamatani

11

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

0 references

publication date

2 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

54

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

764-771

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis c: pretreatment stratification by viral burden and genotype

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholest

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological response.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Randomized trial of high-dose interferon-alpha-2b combined with ribavirin in patients with chronic hepatitis C: Correlation between amino acid substitutions in the core/NS5A region and virological response to interferon therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Hepatitis C virus replication in mice with chimeric human livers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Practical evaluation of a mouse with chimeric human liver model for hepatitis C virus infection using an NS3-4A protease inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Near completely humanized liver in mice shows human-type metabolic responses to drugs

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis C virus and its susceptibility to interferon.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Establishment of an infectious genotype 1b hepatitis C virus clone in human hepatocyte chimeric mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Production of Infectious Hepatitis C Virus of Various Genotypes in Cell Cultures

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Internal Initiation Stimulates Production of p8 Minicore, a Member of a Newly Discovered Family of Hepatitis C Virus Core Protein Isoforms

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

Interferon signaling and treatment outcome in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

A high-throughput SNP typing system for genome-wide association studies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

21 January 2018

The dinucleotide microsatellite polymorphism of the IFNAR1 gene promoter correlates with responsiveness of hepatitis C patients to interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24453

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.24453

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43037177&oldid=1978284903"